Salidroside, the primary active ingredient found in the plant Rhodiola rosea, exhibits the capacity to enhance NAFLD through the microbiota-BA-FXR axis and the AMPK-dependent TXNIP/NLRP3 pathway [53, 54]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.